Stock HEMISPHERX BIOPHARMA, INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Official Publications Hemispherx BioPharma, Inc Nyse

Equities

End-of-day quote Nyse
Other stock markets
- USD - Intraday chart for Hemispherx BioPharma, Inc
Apr. 10 AIM Immunotech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer CI
Apr. 02 Transcript : AIM ImmunoTech Inc., Q4 2023 Earnings Call, Apr 02, 2024

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. AIM Stock
  4. Stock
  5. News Hemispherx BioPharma, Inc
  6. Official Publications